-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ODMCRY2drfkoev1sdLWhSCAg15kmDocqI5xDmYLk8Fk52inUoqZfuj2Kjkyem1vs P5hJZ4D7GyA1UawcO12BKA== 0000950129-97-001026.txt : 19970314 0000950129-97-001026.hdr.sgml : 19970314 ACCESSION NUMBER: 0000950129-97-001026 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19970313 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEXAS BIOTECHNOLOGY CORP /DE/ CENTRAL INDEX KEY: 0000887023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133532643 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-20117 FILM NUMBER: 97556079 BUSINESS ADDRESS: STREET 1: DOCTORS CENTER STREET 2: 7000 FANNIN STE 1920 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: 7137968822 10-K/A 1 TEXAS BIOTECHNOLOGY CORPORATION - 12/31/96 1 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [No Fee Required] For the Fiscal Year Ended December 31, 1996 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [No Fee Required] Commission File Number: 1-12574 TEXAS BIOTECHNOLOGY CORPORATION (Exact name of Registrant as specified in its charter) Delaware 13-3532643 (State of Incorporation) (I.R.S. Employer Identification Number) 7000 Fannin, Suite 1920 Houston, Texas 77030 (713) 796-8822 (Address and telephone number of principal executive offices and zip code) Securities registered pursuant to Section 12(b) of the Act:
Name of Each Exchange Title of Each Class on Which Registered ------------------- ------------------- Common Stock, $.005 par value American Stock Exchange Redeemable common stock purchase warrants American Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.005 par value Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceeding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No --- --- The approximate aggregate market value of voting stock held by nonaffiliates of the registrant is $146,527,000 as of February 28, 1997. Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] The number of shares outstanding of each of the registrant's classes of common stock as of February 28, 1997:
Title of Class Number of Shares -------------- ---------------- Common Stock, $.005 par value 25,491,603
Documents incorporated by reference:
Document Form 10-K Parts -------- --------------- Definitive Proxy Statement, to be filed within 120 days of III December 31, 1996 (specified portions)
================================================================================ 2 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Houston and State of Texas on the 13th day of March, 1997. TEXAS BIOTECHNOLOGY CORPORATION By: /s/ STEPHEN L. MUELLER ---------------------------------------- Stephen L. Mueller Vice President of Administration, Secretary and Treasurer -----END PRIVACY-ENHANCED MESSAGE-----